Publication Date:
1984-12-21
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Sun, M -- New York, N.Y. -- Science. 1984 Dec 21;226(4681):1404-5.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6594758" target="_blank"〉PubMed〈/a〉
Keywords:
Advisory Committees
;
Containment of Biohazards
;
Ethics Committees, Research
;
Federal Government
;
Genetic Diseases, Inborn
;
*Genetic Engineering
;
Government Regulation
;
Judicial Role
;
Jurisprudence
;
*National Institutes of Health (U.S.)
;
United States
;
Administration, the first authorized experiments in human gene therapy are
;
expected to begin sometime in 1985. Anticipating approval, the congressional
;
Office of Technology Assessment (OTA), at the request of then Representative
;
Albert Gore, Jr. (D-Tenn), compiled a report on the scientific and ethical issues
;
involved. OTA found no unique ethical obstacles to somatic cell therapy if
;
conducted safely and with a reasonable expectation of efficacy. It reached no
;
agreement concerning the necessity, feasibility, or ethical acceptability of
;
germline therapy, and recommended further evaluation and public discussion.
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink